AN2 Therapeutics, Inc. (ANTX) Operating income 2021–2025
AN2 Therapeutics, Inc. (ANTX) annual operating income history from SEC filings — each fiscal year as reported.
-$38.1MFY2025 · since FY2021: -$21.6M → -$38.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$38.1M | +32.9% |
| FY2024 | -$56.8M | +18.4% |
| FY2023 | -$69.6M | -64.8% |
| FY2022 | -$42.3M | -95.9% |
| FY2021 | -$21.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice